A case of generalized morphea profunda following SARS-CoV-2 infection.

Stephens, Michael R; Moore, Duncan F; Dau, Jonathan; Jobbagy, Soma; Neel, Victor A; Bolster, Marcy B; Fedeles, Flavia

Stephens, Michael R; Moore, Duncan F; Dau, Jonathan; Jobbagy, Soma; Neel, Victor A; Bolster, Marcy B; Fedeles, Flavia.

Afiliação

Stephens MR; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Moore DF; Division of Rheumatology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Dau J; UC Health Cherry Creek, Denver, Colorado.
Jobbagy S; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Neel VA; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Bolster MB; Division of Rheumatology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Fedeles F; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

JAAD Case Rep ; 23: 20-23, 2022 May.

Article em En | MEDLINE | ID: mdl-35308063

Palavras-chave

IL, interleukin; SARS-CoV-2; fibrosing skin disorder; inflammatory cytokines; morphea; tocilizumab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JAAD Case Rep Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google